Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Hamilton

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BMC Cancer|September 5, 2009
Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trialJohan Vansteenkiste, Michael Hedenus, Pere Gascon, et al.
Pharmaceutical Research|June 9, 2017
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine SubjectsThuy Vu, Peiming Ma, Jiyun Sunny Chen, et al.
Clinical Pharmacology in Drug Development|January 25, 2019
Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and SafetyEdward Lee, John P Gibbs, Maurice G Emery, et al.
Clinical Pharmacology and Therapeutics|July 25, 2017
Phase I, Randomized, Double-blind, Placebo-controlled, Single-dose, and Multiple-dose Studies of Erenumab in Healthy Subjects and Patients With MigraineJan de Hoon, Anne Van Hecken, Corinne Vandermeulen, et al.
Journal of Clinical Pharmacology|September 27, 2016
Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic ImpairmentJohn P Gibbs, J Greg Slatter, Ogo Egbuna, et al.
Leukemia & Lymphoma|February 23, 2011
Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational studyCorinne Haioun, Antonio Salar, Ruth Pettengell, et al.
Histopathology|February 14, 2013
Outcome of pure mucocele-like lesions diagnosed on breast core biopsyEmad A Rakha, Abeer M Shaaban, Syeda Asma Haider, et al.
Southern Medical Journal|April 18, 2026
Empowering the Community Health Worker Role in the Stroke Continuum of Care: Development of the Florida Stroke Registry CHW Stroke Training ProgramEsmeralda Segura, Farya Fakoori, Christina Ampie, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMC Cancer|September 5, 2009
Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trialJohan Vansteenkiste, Michael Hedenus, Pere Gascon, et al.
Pharmaceutical Research|June 9, 2017
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine SubjectsThuy Vu, Peiming Ma, Jiyun Sunny Chen, et al.
Clinical Pharmacology in Drug Development|January 25, 2019
Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and SafetyEdward Lee, John P Gibbs, Maurice G Emery, et al.
Clinical Pharmacology and Therapeutics|July 25, 2017
Phase I, Randomized, Double-blind, Placebo-controlled, Single-dose, and Multiple-dose Studies of Erenumab in Healthy Subjects and Patients With MigraineJan de Hoon, Anne Van Hecken, Corinne Vandermeulen, et al.
Journal of Clinical Pharmacology|September 27, 2016
Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic ImpairmentJohn P Gibbs, J Greg Slatter, Ogo Egbuna, et al.
Leukemia & Lymphoma|February 23, 2011
Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational studyCorinne Haioun, Antonio Salar, Ruth Pettengell, et al.
Histopathology|February 14, 2013
Outcome of pure mucocele-like lesions diagnosed on breast core biopsyEmad A Rakha, Abeer M Shaaban, Syeda Asma Haider, et al.
Southern Medical Journal|April 18, 2026
Empowering the Community Health Worker Role in the Stroke Continuum of Care: Development of the Florida Stroke Registry CHW Stroke Training ProgramEsmeralda Segura, Farya Fakoori, Christina Ampie, et al.
Pageof 2